InvestorsHub Logo
Followers 13
Posts 1563
Boards Moderated 0
Alias Born 06/14/2018

Re: None

Wednesday, 05/31/2023 11:53:49 AM

Wednesday, May 31, 2023 11:53:49 AM

Post# of 34750
Just to play devils advocate ... Yep sounds good ... Pre Clinical in a Test Tube, but how many hundreds of other experiments seemed to work Pre Clinical in a Test Tube and then went nowhere, or worked in mice and then went nowhere, or seemed to work in phase 1 and then went nowhere.
Like LC, I also remember Peregrine (my second biggest loser after MRKR). I don't think I will be adding more shares on this rubberband stretching news.
We have about 9 million shares outstanding and about 33 million shares Traded so far, up to $1.95 and then the drift down started and buyers at $1.80, $1.85, $1.90, $1.95 are currently losing $. Most of those Traders could care less about the news, they are just playing momentum.
If I poured battery acid in a test tube and killed lymphoma cells, they would probably be playing that momentum also.
Buy on the rumor, Sell on the news. The news I would like to hear about is AML Adjuvant.
But I guess todays news is better than "we did X pre clinical in a test tube and it sucked."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News